Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Page C. Moore"'
Autor:
Jeffrey R. Curtis, Robert R. McLean, I‐Heng Lee, Rachel H. Mackey, Page C. Moore, Richard Haubrich, Jeffrey D. Greenberg, Alicea Wu
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 5, Pp 253-264 (2024)
Objective To describe and identify associated factors for patient–clinician discordance of disease assessment at biologic or Janus kinase inhibitor (JAKi) initiation and over 12 months following initiation in patients with rheumatoid arthritis (RA)
Externí odkaz:
https://doaj.org/article/6c378415e1284b08b0037905b3d6a940
Autor:
Joshua F. Baker, Catherine Bakewell, Ara Dikranian, Gordon Lam, Jacqueline O’Brien, Page C. Moore, Miao Yu, Peter Hur, Karim R. Masri
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 3, Pp 841-853 (2024)
Abstract Introduction Real-world studies describing biosimilar initiation or switching in patients with rheumatoid arthritis (RA) are limited. The aim of this study was to assess treatment patterns and effectiveness of real-world patients with RA ini
Externí odkaz:
https://doaj.org/article/67521a50405f43d9883fc2ca5b204a32
Autor:
Leslie R. Harrold, Keith Wittstock, Sheila Kelly, Xue Han, Joe Zhuo, Amy Schrader, Nicole Middaugh, Page C. Moore, Vadim Khaychuk
Publikováno v:
Advances in Rheumatology, Vol 64, Iss 1, Pp 1-11 (2024)
Abstract Background The HLA-DRB1 shared epitope (SE) is a risk factor for the development of rheumatoid arthritis (RA) and the production of anti-citrullinated protein antibodies (ACPAs) in RA patients. Our objective was to examine the real-world eff
Externí odkaz:
https://doaj.org/article/fe935ce0ec0c4b219778878a6c299874
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
Autor:
Leslie R. Harrold, Keith Wittstock, Sheila Kelly, Xue Han, Ying Shan, Lin Guo, Page C. Moore, Vadim Khaychuk
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 3, Pp 575-587 (2023)
Abstract Introduction Currently there is limited data to drive clinical decision making regarding the choice of biologic/targeted synthetic disease-modifying antirheumatic drugs (DMARD); thus, head-to-head comparisons are needed to help guide prescri
Externí odkaz:
https://doaj.org/article/242a5d4c95ca444e82ba8baa68442026
Autor:
Douglas C. Wolf, April N. Naegeli, Page C. Moore, Jud C. Janak, Margaux M. Crabtree, Mingyang Shan, Theresa M. Hunter, Angelina Sontag, Raymond K. Cross
Publikováno v:
Gastro Hep Advances, Vol 2, Iss 6, Pp 799-809 (2023)
Background and Aims: Fecal urgency is a common symptom of Ulcerative Colitis (UC). We explored the association between changes in fecal urgency for patient characteristics and evaluated the association between change in treatment and change in fecal
Externí odkaz:
https://doaj.org/article/d0559694a29d41378ca38f9362f5054c
Publikováno v:
Audiology Research, Vol 2, Iss 1 (2012)
Auditory brainstem response (ABR) peak measures were compared for a custom ear canal electrode and traditional mastoid and ear lobe reference electrode sites with the assumption that the ear canal electrode would yield larger Wave I amplitudes. In th
Externí odkaz:
https://doaj.org/article/3ad0cf92f2ee4dc98a65b30074f93b80
Publikováno v:
Journal of Cancer Epidemiology, Vol 2012 (2012)
The incidence of lung cancer among individuals infected with the human immunodeficiency virus (HIV) is elevated compared to that among the general population. This study examines the prevalence of HIV and its impact on outcomes among Medicare benefic
Externí odkaz:
https://doaj.org/article/e72d5a2b42754002a651f318607d7bbd
Autor:
Yanni Fan, Sílvia Delgado-Aros, Wendell C. Valdecantos, Jud C. Janak, Page C. Moore, Margaux M. Crabtree, Ryan W. Stidham
Publikováno v:
Digestive Diseases and Sciences. 68:214-222
Autor:
Linda A. Feagins, Page C. Moore, Margaux M. Crabtree, Celeste A. Lemay, Anita M. Loughlin, Jill K. Gaidos
Publikováno v:
American Journal of Gastroenterology. 117:e639-e640
Autor:
Raymond K Cross, April N Naegeli, Ryan W Harrison, Page C Moore, Rachel H Mackey, Margaux M Crabtree, Celeste A Lemay, Vipin Arora, Nathan Morris, Angelina Sontag, Cem Kayhan, Joshua R Korzenik
Publikováno v:
Crohn's & Colitis 360. 4
Background To evaluate disease burden and patient-reported outcomes (PROs) of ulcerative colitis (UC) patients at enrollment into CorEvitas’ Inflammatory Bowel Disease Registry by therapy class. Methods Between May 3, 2017 and September 3, 2019, 77